nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP2E1—Dacarbazine—muscle cancer	0.102	0.166	CbGbCtD
Amitriptyline—CYP1A2—Dacarbazine—muscle cancer	0.0591	0.0962	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—muscle cancer	0.05	0.0814	CbGbCtD
Amitriptyline—ABCB1—Dactinomycin—muscle cancer	0.0448	0.0729	CbGbCtD
Amitriptyline—CYP3A5—Vincristine—muscle cancer	0.0424	0.069	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—muscle cancer	0.0388	0.0633	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—muscle cancer	0.0373	0.0608	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—muscle cancer	0.0336	0.0548	CbGbCtD
Amitriptyline—ALB—Methotrexate—muscle cancer	0.0319	0.052	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—muscle cancer	0.0289	0.0471	CbGbCtD
Amitriptyline—ABCB1—Vincristine—muscle cancer	0.0276	0.0449	CbGbCtD
Amitriptyline—ABCB1—Etoposide—muscle cancer	0.0253	0.0412	CbGbCtD
Amitriptyline—ABCB1—Doxorubicin—muscle cancer	0.0172	0.0281	CbGbCtD
Amitriptyline—ABCB1—Methotrexate—muscle cancer	0.0167	0.0272	CbGbCtD
Amitriptyline—CYP3A4—Vincristine—muscle cancer	0.0165	0.0269	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—muscle cancer	0.0162	0.0265	CbGbCtD
Amitriptyline—CYP3A4—Etoposide—muscle cancer	0.0151	0.0247	CbGbCtD
Amitriptyline—CYP3A4—Doxorubicin—muscle cancer	0.0103	0.0168	CbGbCtD
Amitriptyline—CHRM3—muscle of abdomen—muscle cancer	0.00995	0.0789	CbGeAlD
Amitriptyline—Mental status changes—Vincristine—muscle cancer	0.00771	0.0521	CcSEcCtD
Amitriptyline—Paresthesia of limbs—Methotrexate—muscle cancer	0.0046	0.0311	CcSEcCtD
Amitriptyline—Ileus paralytic—Vincristine—muscle cancer	0.0042	0.0284	CcSEcCtD
Amitriptyline—NTRK1—testis—muscle cancer	0.00387	0.0307	CbGeAlD
Amitriptyline—HRH4—bone marrow—muscle cancer	0.0037	0.0294	CbGeAlD
Amitriptyline—NTRK2—bone marrow—muscle cancer	0.00346	0.0275	CbGeAlD
Amitriptyline—Inappropriate antidiuretic hormone secretion—Vincristine—muscle cancer	0.00313	0.0211	CcSEcCtD
Amitriptyline—NTRK2—head—muscle cancer	0.00307	0.0243	CbGeAlD
Amitriptyline—HTR2A—hindlimb—muscle cancer	0.00302	0.024	CbGeAlD
Amitriptyline—NTRK2—testis—muscle cancer	0.00296	0.0235	CbGeAlD
Amitriptyline—Bone marrow depression—Vincristine—muscle cancer	0.00269	0.0182	CcSEcCtD
Amitriptyline—HTR2A—appendage—muscle cancer	0.00259	0.0206	CbGeAlD
Amitriptyline—KCND3—cardiac atrium—muscle cancer	0.00236	0.0188	CbGeAlD
Amitriptyline—KCNQ3—head—muscle cancer	0.00232	0.0184	CbGeAlD
Amitriptyline—Numbness—Vincristine—muscle cancer	0.00219	0.0148	CcSEcCtD
Amitriptyline—OPRD1—renal system—muscle cancer	0.00217	0.0172	CbGeAlD
Amitriptyline—KCNQ2—head—muscle cancer	0.00214	0.017	CbGeAlD
Amitriptyline—Sensory loss—Vincristine—muscle cancer	0.0021	0.0142	CcSEcCtD
Amitriptyline—KCNA1—tendon—muscle cancer	0.00207	0.0164	CbGeAlD
Amitriptyline—KCNQ2—testis—muscle cancer	0.00207	0.0164	CbGeAlD
Amitriptyline—KCND2—head—muscle cancer	0.00203	0.0161	CbGeAlD
Amitriptyline—KCND2—testis—muscle cancer	0.00196	0.0155	CbGeAlD
Amitriptyline—HRH2—cardiac atrium—muscle cancer	0.00184	0.0146	CbGeAlD
Amitriptyline—Tingling sensation—Etoposide—muscle cancer	0.00183	0.0124	CcSEcCtD
Amitriptyline—ADRA1B—renal system—muscle cancer	0.0018	0.0142	CbGeAlD
Amitriptyline—Numbness—Etoposide—muscle cancer	0.00178	0.012	CcSEcCtD
Amitriptyline—KCNA1—head—muscle cancer	0.00177	0.0141	CbGeAlD
Amitriptyline—KCND3—head—muscle cancer	0.00177	0.014	CbGeAlD
Amitriptyline—KCND3—testis—muscle cancer	0.00171	0.0135	CbGeAlD
Amitriptyline—Sensory loss—Etoposide—muscle cancer	0.0017	0.0115	CcSEcCtD
Amitriptyline—CHRM4—head—muscle cancer	0.00168	0.0133	CbGeAlD
Amitriptyline—Coma—Vincristine—muscle cancer	0.00166	0.0112	CcSEcCtD
Amitriptyline—Hepatic failure—Dactinomycin—muscle cancer	0.00164	0.0111	CcSEcCtD
Amitriptyline—CHRM4—testis—muscle cancer	0.00162	0.0129	CbGeAlD
Amitriptyline—DRD3—head—muscle cancer	0.00156	0.0124	CbGeAlD
Amitriptyline—Bundle branch block—Doxorubicin—muscle cancer	0.00151	0.0102	CcSEcCtD
Amitriptyline—HTR6—head—muscle cancer	0.00151	0.0119	CbGeAlD
Amitriptyline—Cardiomyopathy—Doxorubicin—muscle cancer	0.00149	0.0101	CcSEcCtD
Amitriptyline—Hepatic failure—Vincristine—muscle cancer	0.00147	0.00991	CcSEcCtD
Amitriptyline—OPRD1—head—muscle cancer	0.00145	0.0115	CbGeAlD
Amitriptyline—OPRK1—head—muscle cancer	0.00139	0.0111	CbGeAlD
Amitriptyline—HRH2—head—muscle cancer	0.00138	0.0109	CbGeAlD
Amitriptyline—CHRM5—head—muscle cancer	0.00131	0.0104	CbGeAlD
Amitriptyline—Bone marrow depression—Methotrexate—muscle cancer	0.00131	0.00882	CcSEcCtD
Amitriptyline—SIGMAR1—smooth muscle tissue—muscle cancer	0.00127	0.0101	CbGeAlD
Amitriptyline—Urinary retention—Vincristine—muscle cancer	0.00125	0.00847	CcSEcCtD
Amitriptyline—Ataxia—Vincristine—muscle cancer	0.00124	0.00838	CcSEcCtD
Amitriptyline—Pancytopenia—Dactinomycin—muscle cancer	0.00121	0.00818	CcSEcCtD
Amitriptyline—ADRA1B—head—muscle cancer	0.0012	0.00953	CbGeAlD
Amitriptyline—ADRA1D—head—muscle cancer	0.00118	0.00932	CbGeAlD
Amitriptyline—CHRM3—smooth muscle tissue—muscle cancer	0.00114	0.00905	CbGeAlD
Amitriptyline—Bone marrow depression—Doxorubicin—muscle cancer	0.00113	0.00764	CcSEcCtD
Amitriptyline—Stomatitis—Dactinomycin—muscle cancer	0.00111	0.00749	CcSEcCtD
Amitriptyline—CHRM3—renal system—muscle cancer	0.0011	0.00872	CbGeAlD
Amitriptyline—SIGMAR1—cardiac atrium—muscle cancer	0.0011	0.0087	CbGeAlD
Amitriptyline—HTR1A—renal system—muscle cancer	0.00109	0.00868	CbGeAlD
Amitriptyline—ORM1—bone marrow—muscle cancer	0.00109	0.00868	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—muscle cancer	0.00109	0.00862	CbGeAlD
Amitriptyline—Pancytopenia—Vincristine—muscle cancer	0.00108	0.00731	CcSEcCtD
Amitriptyline—Agranulocytosis—Dactinomycin—muscle cancer	0.00106	0.00717	CcSEcCtD
Amitriptyline—Erectile dysfunction—Vincristine—muscle cancer	0.00105	0.00709	CcSEcCtD
Amitriptyline—HTR7—renal system—muscle cancer	0.00105	0.0083	CbGeAlD
Amitriptyline—Hepatitis—Dactinomycin—muscle cancer	0.00102	0.0069	CcSEcCtD
Amitriptyline—ADRA1A—renal system—muscle cancer	0.00101	0.008	CbGeAlD
Amitriptyline—Acute coronary syndrome—Vincristine—muscle cancer	0.001	0.00677	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Vincristine—muscle cancer	0.000997	0.00673	CcSEcCtD
Amitriptyline—Myocardial infarction—Vincristine—muscle cancer	0.000997	0.00673	CcSEcCtD
Amitriptyline—OPRM1—head—muscle cancer	0.000991	0.00787	CbGeAlD
Amitriptyline—Stomatitis—Vincristine—muscle cancer	0.000991	0.00669	CcSEcCtD
Amitriptyline—OPRM1—testis—muscle cancer	0.000958	0.0076	CbGeAlD
Amitriptyline—SIGMAR1—tendon—muscle cancer	0.000955	0.00758	CbGeAlD
Amitriptyline—Ageusia—Doxorubicin—muscle cancer	0.000943	0.00636	CcSEcCtD
Amitriptyline—Dysarthria—Methotrexate—muscle cancer	0.000932	0.00629	CcSEcCtD
Amitriptyline—SIGMAR1—bone marrow—muscle cancer	0.000925	0.00734	CbGeAlD
Amitriptyline—Hypoaesthesia—Vincristine—muscle cancer	0.000908	0.00613	CcSEcCtD
Amitriptyline—Hallucination—Vincristine—muscle cancer	0.000908	0.00613	CcSEcCtD
Amitriptyline—HTR1B—head—muscle cancer	0.000907	0.0072	CbGeAlD
Amitriptyline—Alopecia—Dactinomycin—muscle cancer	0.000903	0.00609	CcSEcCtD
Amitriptyline—CHRM2—head—muscle cancer	0.000902	0.00716	CbGeAlD
Amitriptyline—Sweating increased—Etoposide—muscle cancer	0.0009	0.00607	CcSEcCtD
Amitriptyline—CYP2C8—renal system—muscle cancer	0.000891	0.00707	CbGeAlD
Amitriptyline—SIGMAR1—vagina—muscle cancer	0.000887	0.00703	CbGeAlD
Amitriptyline—HTR1D—head—muscle cancer	0.000878	0.00697	CbGeAlD
Amitriptyline—Pancytopenia—Etoposide—muscle cancer	0.000877	0.00592	CcSEcCtD
Amitriptyline—HTR2C—head—muscle cancer	0.00087	0.0069	CbGeAlD
Amitriptyline—HTR2A—embryo—muscle cancer	0.000862	0.00684	CbGeAlD
Amitriptyline—CYP1A2—renal system—muscle cancer	0.000834	0.00662	CbGeAlD
Amitriptyline—Ill-defined disorder—Dactinomycin—muscle cancer	0.000825	0.00557	CcSEcCtD
Amitriptyline—SLC6A4—head—muscle cancer	0.000825	0.00654	CbGeAlD
Amitriptyline—CHRM1—head—muscle cancer	0.000821	0.00652	CbGeAlD
Amitriptyline—ALB—testis—muscle cancer	0.00082	0.0065	CbGeAlD
Amitriptyline—HTR7—tendon—muscle cancer	0.000816	0.00648	CbGeAlD
Amitriptyline—Dyskinesia—Doxorubicin—muscle cancer	0.000813	0.00549	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Etoposide—muscle cancer	0.000812	0.00548	CcSEcCtD
Amitriptyline—HRH1—smooth muscle tissue—muscle cancer	0.000811	0.00644	CbGeAlD
Amitriptyline—Dysarthria—Doxorubicin—muscle cancer	0.000807	0.00545	CcSEcCtD
Amitriptyline—Myocardial infarction—Etoposide—muscle cancer	0.000807	0.00545	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Etoposide—muscle cancer	0.000807	0.00545	CcSEcCtD
Amitriptyline—Alopecia—Vincristine—muscle cancer	0.000807	0.00545	CcSEcCtD
Amitriptyline—Coma—Methotrexate—muscle cancer	0.000806	0.00544	CcSEcCtD
Amitriptyline—CYP3A5—renal system—muscle cancer	0.000804	0.00638	CbGeAlD
Amitriptyline—Jaundice—Etoposide—muscle cancer	0.000803	0.00542	CcSEcCtD
Amitriptyline—Stomatitis—Etoposide—muscle cancer	0.000803	0.00542	CcSEcCtD
Amitriptyline—Malaise—Dactinomycin—muscle cancer	0.000802	0.00541	CcSEcCtD
Amitriptyline—CYP2B6—renal system—muscle cancer	0.000799	0.00634	CbGeAlD
Amitriptyline—Leukopenia—Dactinomycin—muscle cancer	0.000796	0.00537	CcSEcCtD
Amitriptyline—SIGMAR1—testis—muscle cancer	0.000791	0.00628	CbGeAlD
Amitriptyline—Gynaecomastia—Methotrexate—muscle cancer	0.000789	0.00533	CcSEcCtD
Amitriptyline—Atrioventricular block—Doxorubicin—muscle cancer	0.000787	0.00532	CcSEcCtD
Amitriptyline—Coordination abnormal—Doxorubicin—muscle cancer	0.000778	0.00525	CcSEcCtD
Amitriptyline—Agranulocytosis—Etoposide—muscle cancer	0.000769	0.00519	CcSEcCtD
Amitriptyline—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000764	0.00516	CcSEcCtD
Amitriptyline—CYP2E1—renal system—muscle cancer	0.00075	0.00595	CbGeAlD
Amitriptyline—Discomfort—Dactinomycin—muscle cancer	0.000748	0.00505	CcSEcCtD
Amitriptyline—CYP2C19—vagina—muscle cancer	0.00074	0.00587	CbGeAlD
Amitriptyline—Hypoaesthesia—Etoposide—muscle cancer	0.000736	0.00497	CcSEcCtD
Amitriptyline—CHRM3—head—muscle cancer	0.000735	0.00583	CbGeAlD
Amitriptyline—HTR1A—head—muscle cancer	0.000732	0.00581	CbGeAlD
Amitriptyline—Agitation—Vincristine—muscle cancer	0.00073	0.00493	CcSEcCtD
Amitriptyline—SLC6A2—head—muscle cancer	0.000726	0.00576	CbGeAlD
Amitriptyline—Oedema—Dactinomycin—muscle cancer	0.000726	0.0049	CcSEcCtD
Amitriptyline—Hepatic failure—Methotrexate—muscle cancer	0.000712	0.00481	CcSEcCtD
Amitriptyline—Leukopenia—Vincristine—muscle cancer	0.000711	0.0048	CcSEcCtD
Amitriptyline—Thrombocytopenia—Dactinomycin—muscle cancer	0.000711	0.0048	CcSEcCtD
Amitriptyline—CHRM3—testis—muscle cancer	0.00071	0.00563	CbGeAlD
Amitriptyline—SLC6A2—testis—muscle cancer	0.000701	0.00556	CbGeAlD
Amitriptyline—HTR7—head—muscle cancer	0.0007	0.00555	CbGeAlD
Amitriptyline—Coma—Doxorubicin—muscle cancer	0.000698	0.00471	CcSEcCtD
Amitriptyline—Anorexia—Dactinomycin—muscle cancer	0.000692	0.00467	CcSEcCtD
Amitriptyline—Convulsion—Vincristine—muscle cancer	0.000688	0.00465	CcSEcCtD
Amitriptyline—ADRA2A—cardiac atrium—muscle cancer	0.000687	0.00545	CbGeAlD
Amitriptyline—Hypertension—Vincristine—muscle cancer	0.000686	0.00463	CcSEcCtD
Amitriptyline—HTR2A—smooth muscle tissue—muscle cancer	0.000677	0.00537	CbGeAlD
Amitriptyline—HTR7—testis—muscle cancer	0.000676	0.00536	CbGeAlD
Amitriptyline—ADRA1A—head—muscle cancer	0.000675	0.00535	CbGeAlD
Amitriptyline—Mental disability—Doxorubicin—muscle cancer	0.000663	0.00447	CcSEcCtD
Amitriptyline—DRD2—head—muscle cancer	0.000662	0.00525	CbGeAlD
Amitriptyline—Alopecia—Etoposide—muscle cancer	0.000653	0.00441	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Methotrexate—muscle cancer	0.000653	0.00441	CcSEcCtD
Amitriptyline—HTR2A—renal system—muscle cancer	0.000652	0.00517	CbGeAlD
Amitriptyline—Oedema—Vincristine—muscle cancer	0.000648	0.00438	CcSEcCtD
Amitriptyline—CYP2C8—vagina—muscle cancer	0.000646	0.00512	CbGeAlD
Amitriptyline—Osteoarthritis—Methotrexate—muscle cancer	0.00064	0.00432	CcSEcCtD
Amitriptyline—DRD2—testis—muscle cancer	0.000639	0.00507	CbGeAlD
Amitriptyline—Thrombocytopenia—Vincristine—muscle cancer	0.000635	0.00429	CcSEcCtD
Amitriptyline—Decreased appetite—Dactinomycin—muscle cancer	0.000631	0.00426	CcSEcCtD
Amitriptyline—Dysgeusia—Etoposide—muscle cancer	0.00063	0.00426	CcSEcCtD
Amitriptyline—Hyperhidrosis—Vincristine—muscle cancer	0.000627	0.00423	CcSEcCtD
Amitriptyline—Fatigue—Dactinomycin—muscle cancer	0.000626	0.00422	CcSEcCtD
Amitriptyline—Vascular purpura—Doxorubicin—muscle cancer	0.00062	0.00418	CcSEcCtD
Amitriptyline—Anorexia—Vincristine—muscle cancer	0.000618	0.00417	CcSEcCtD
Amitriptyline—Hepatic failure—Doxorubicin—muscle cancer	0.000617	0.00416	CcSEcCtD
Amitriptyline—Irritability—Methotrexate—muscle cancer	0.000611	0.00413	CcSEcCtD
Amitriptyline—HRH1—tendon—muscle cancer	0.000609	0.00484	CbGeAlD
Amitriptyline—Hypotension—Vincristine—muscle cancer	0.000606	0.00409	CcSEcCtD
Amitriptyline—CYP3A4—renal system—muscle cancer	0.000604	0.00479	CbGeAlD
Amitriptyline—Ataxia—Methotrexate—muscle cancer	0.000602	0.00406	CcSEcCtD
Amitriptyline—ADRA2A—tendon—muscle cancer	0.000599	0.00475	CbGeAlD
Amitriptyline—Feeling abnormal—Dactinomycin—muscle cancer	0.000598	0.00404	CcSEcCtD
Amitriptyline—Ill-defined disorder—Etoposide—muscle cancer	0.000597	0.00403	CcSEcCtD
Amitriptyline—CYP2D6—renal system—muscle cancer	0.000594	0.00471	CbGeAlD
Amitriptyline—Insomnia—Vincristine—muscle cancer	0.000587	0.00396	CcSEcCtD
Amitriptyline—CYP2E1—tendon—muscle cancer	0.000586	0.00465	CbGeAlD
Amitriptyline—CYP3A5—vagina—muscle cancer	0.000583	0.00462	CbGeAlD
Amitriptyline—Paraesthesia—Vincristine—muscle cancer	0.000582	0.00393	CcSEcCtD
Amitriptyline—Malaise—Etoposide—muscle cancer	0.00058	0.00392	CcSEcCtD
Amitriptyline—CYP2B6—vagina—muscle cancer	0.000579	0.00459	CbGeAlD
Amitriptyline—Leukopenia—Etoposide—muscle cancer	0.000576	0.00389	CcSEcCtD
Amitriptyline—CYP2C8—testis—muscle cancer	0.000576	0.00457	CbGeAlD
Amitriptyline—Purpura—Doxorubicin—muscle cancer	0.000575	0.00388	CcSEcCtD
Amitriptyline—Body temperature increased—Dactinomycin—muscle cancer	0.000574	0.00387	CcSEcCtD
Amitriptyline—Loss of consciousness—Etoposide—muscle cancer	0.000566	0.00382	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000566	0.00382	CcSEcCtD
Amitriptyline—HRH1—vagina—muscle cancer	0.000566	0.00449	CbGeAlD
Amitriptyline—ABCB1—embryo—muscle cancer	0.000565	0.00448	CbGeAlD
Amitriptyline—Decreased appetite—Vincristine—muscle cancer	0.000564	0.00381	CcSEcCtD
Amitriptyline—Fatigue—Vincristine—muscle cancer	0.000559	0.00377	CcSEcCtD
Amitriptyline—Convulsion—Etoposide—muscle cancer	0.000558	0.00376	CcSEcCtD
Amitriptyline—Hypertension—Etoposide—muscle cancer	0.000556	0.00375	CcSEcCtD
Amitriptyline—ADRA2A—vagina—muscle cancer	0.000556	0.00441	CbGeAlD
Amitriptyline—Constipation—Vincristine—muscle cancer	0.000555	0.00374	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—muscle cancer	0.000554	0.00374	CcSEcCtD
Amitriptyline—Eosinophilia—Methotrexate—muscle cancer	0.000548	0.0037	CcSEcCtD
Amitriptyline—Discomfort—Etoposide—muscle cancer	0.000541	0.00366	CcSEcCtD
Amitriptyline—CYP2B6—head—muscle cancer	0.000535	0.00424	CbGeAlD
Amitriptyline—Confusional state—Etoposide—muscle cancer	0.00053	0.00358	CcSEcCtD
Amitriptyline—Pancytopenia—Methotrexate—muscle cancer	0.000525	0.00355	CcSEcCtD
Amitriptyline—HRH1—head—muscle cancer	0.000522	0.00414	CbGeAlD
Amitriptyline—Ataxia—Doxorubicin—muscle cancer	0.000521	0.00352	CcSEcCtD
Amitriptyline—Asthenia—Dactinomycin—muscle cancer	0.000521	0.00352	CcSEcCtD
Amitriptyline—CYP2B6—testis—muscle cancer	0.000517	0.0041	CbGeAlD
Amitriptyline—Thrombocytopenia—Etoposide—muscle cancer	0.000514	0.00347	CcSEcCtD
Amitriptyline—ADRA2A—head—muscle cancer	0.000513	0.00407	CbGeAlD
Amitriptyline—Tachycardia—Etoposide—muscle cancer	0.000513	0.00346	CcSEcCtD
Amitriptyline—Body temperature increased—Vincristine—muscle cancer	0.000513	0.00346	CcSEcCtD
Amitriptyline—Erectile dysfunction—Methotrexate—muscle cancer	0.00051	0.00344	CcSEcCtD
Amitriptyline—HTR2A—tendon—muscle cancer	0.000509	0.00404	CbGeAlD
Amitriptyline—Hyperhidrosis—Etoposide—muscle cancer	0.000508	0.00343	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000506	0.00342	CcSEcCtD
Amitriptyline—HRH1—testis—muscle cancer	0.000505	0.004	CbGeAlD
Amitriptyline—CYP2E1—head—muscle cancer	0.000502	0.00398	CbGeAlD
Amitriptyline—Anorexia—Etoposide—muscle cancer	0.000501	0.00338	CcSEcCtD
Amitriptyline—Diarrhoea—Dactinomycin—muscle cancer	0.000497	0.00335	CcSEcCtD
Amitriptyline—ADRA2A—testis—muscle cancer	0.000496	0.00393	CbGeAlD
Amitriptyline—Drowsiness—Methotrexate—muscle cancer	0.000493	0.00333	CcSEcCtD
Amitriptyline—Hypotension—Etoposide—muscle cancer	0.000491	0.00331	CcSEcCtD
Amitriptyline—CYP2E1—testis—muscle cancer	0.000485	0.00385	CbGeAlD
Amitriptyline—Stomatitis—Methotrexate—muscle cancer	0.000481	0.00325	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—muscle cancer	0.000474	0.0032	CcSEcCtD
Amitriptyline—HTR2A—vagina—muscle cancer	0.000472	0.00375	CbGeAlD
Amitriptyline—Paraesthesia—Etoposide—muscle cancer	0.000472	0.00318	CcSEcCtD
Amitriptyline—Somnolence—Etoposide—muscle cancer	0.000467	0.00315	CcSEcCtD
Amitriptyline—Asthenia—Vincristine—muscle cancer	0.000465	0.00314	CcSEcCtD
Amitriptyline—Vomiting—Dactinomycin—muscle cancer	0.000461	0.00312	CcSEcCtD
Amitriptyline—Agranulocytosis—Methotrexate—muscle cancer	0.00046	0.00311	CcSEcCtD
Amitriptyline—Rash—Dactinomycin—muscle cancer	0.000458	0.00309	CcSEcCtD
Amitriptyline—Decreased appetite—Etoposide—muscle cancer	0.000457	0.00308	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—muscle cancer	0.000455	0.00307	CcSEcCtD
Amitriptyline—Fatigue—Etoposide—muscle cancer	0.000453	0.00306	CcSEcCtD
Amitriptyline—Constipation—Etoposide—muscle cancer	0.000449	0.00303	CcSEcCtD
Amitriptyline—Diarrhoea—Vincristine—muscle cancer	0.000444	0.003	CcSEcCtD
Amitriptyline—Hepatitis—Methotrexate—muscle cancer	0.000443	0.00299	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—muscle cancer	0.000443	0.00299	CcSEcCtD
Amitriptyline—HTR2A—head—muscle cancer	0.000436	0.00346	CbGeAlD
Amitriptyline—Weight increased—Doxorubicin—muscle cancer	0.000436	0.00294	CcSEcCtD
Amitriptyline—Feeling abnormal—Etoposide—muscle cancer	0.000433	0.00292	CcSEcCtD
Amitriptyline—Nausea—Dactinomycin—muscle cancer	0.000431	0.00291	CcSEcCtD
Amitriptyline—Dizziness—Vincristine—muscle cancer	0.000429	0.00289	CcSEcCtD
Amitriptyline—ABCB1—renal system—muscle cancer	0.000427	0.00339	CbGeAlD
Amitriptyline—Drowsiness—Doxorubicin—muscle cancer	0.000427	0.00288	CcSEcCtD
Amitriptyline—HTR2A—testis—muscle cancer	0.000421	0.00334	CbGeAlD
Amitriptyline—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000419	0.00283	CcSEcCtD
Amitriptyline—Urticaria—Etoposide—muscle cancer	0.000417	0.00282	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—muscle cancer	0.000416	0.00281	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—muscle cancer	0.000416	0.00281	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—muscle cancer	0.000415	0.0028	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—muscle cancer	0.000413	0.00279	CcSEcCtD
Amitriptyline—Vomiting—Vincristine—muscle cancer	0.000412	0.00278	CcSEcCtD
Amitriptyline—Rash—Vincristine—muscle cancer	0.000409	0.00276	CcSEcCtD
Amitriptyline—Dermatitis—Vincristine—muscle cancer	0.000408	0.00276	CcSEcCtD
Amitriptyline—Headache—Vincristine—muscle cancer	0.000406	0.00274	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—muscle cancer	0.000399	0.00269	CcSEcCtD
Amitriptyline—CYP2D6—head—muscle cancer	0.000397	0.00315	CbGeAlD
Amitriptyline—Alopecia—Methotrexate—muscle cancer	0.000391	0.00264	CcSEcCtD
Amitriptyline—Nausea—Vincristine—muscle cancer	0.000385	0.0026	CcSEcCtD
Amitriptyline—CYP2D6—testis—muscle cancer	0.000384	0.00305	CbGeAlD
Amitriptyline—Hepatitis—Doxorubicin—muscle cancer	0.000383	0.00259	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—muscle cancer	0.000382	0.00258	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—muscle cancer	0.000378	0.00255	CcSEcCtD
Amitriptyline—Asthenia—Etoposide—muscle cancer	0.000377	0.00254	CcSEcCtD
Amitriptyline—Pruritus—Etoposide—muscle cancer	0.000372	0.00251	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—muscle cancer	0.000363	0.00245	CcSEcCtD
Amitriptyline—Diarrhoea—Etoposide—muscle cancer	0.000359	0.00243	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—muscle cancer	0.000358	0.00241	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—muscle cancer	0.000358	0.00241	CcSEcCtD
Amitriptyline—Malaise—Methotrexate—muscle cancer	0.000348	0.00235	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—muscle cancer	0.000347	0.00235	CcSEcCtD
Amitriptyline—Leukopenia—Methotrexate—muscle cancer	0.000345	0.00233	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—muscle cancer	0.000343	0.00231	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—muscle cancer	0.000339	0.00229	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—muscle cancer	0.000334	0.00226	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—muscle cancer	0.000334	0.00225	CcSEcCtD
Amitriptyline—Rash—Etoposide—muscle cancer	0.000331	0.00224	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—muscle cancer	0.000331	0.00223	CcSEcCtD
Amitriptyline—Headache—Etoposide—muscle cancer	0.000329	0.00222	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—muscle cancer	0.000327	0.00221	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—muscle cancer	0.000324	0.00219	CcSEcCtD
Amitriptyline—ABCB1—bone marrow—muscle cancer	0.000323	0.00256	CbGeAlD
Amitriptyline—Confusional state—Methotrexate—muscle cancer	0.000317	0.00214	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—muscle cancer	0.000315	0.00212	CcSEcCtD
Amitriptyline—Nausea—Etoposide—muscle cancer	0.000312	0.00211	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—muscle cancer	0.00031	0.00209	CcSEcCtD
Amitriptyline—ABCB1—vagina—muscle cancer	0.00031	0.00246	CbGeAlD
Amitriptyline—Thrombocytopenia—Methotrexate—muscle cancer	0.000308	0.00208	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—muscle cancer	0.000307	0.00207	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—muscle cancer	0.000304	0.00205	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—muscle cancer	0.000301	0.00203	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—muscle cancer	0.0003	0.00202	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—muscle cancer	0.000299	0.00202	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—muscle cancer	0.000299	0.00202	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—muscle cancer	0.000295	0.00199	CcSEcCtD
Amitriptyline—Hypotension—Methotrexate—muscle cancer	0.000294	0.00198	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—muscle cancer	0.000293	0.00198	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—muscle cancer	0.000289	0.00195	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—muscle cancer	0.000288	0.00195	CcSEcCtD
Amitriptyline—ABCB1—head—muscle cancer	0.000286	0.00227	CbGeAlD
Amitriptyline—Insomnia—Methotrexate—muscle cancer	0.000285	0.00192	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—muscle cancer	0.000283	0.00191	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—muscle cancer	0.000283	0.00191	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—muscle cancer	0.000281	0.0019	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—muscle cancer	0.00028	0.00189	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—muscle cancer	0.000278	0.00188	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—muscle cancer	0.000277	0.00187	CcSEcCtD
Amitriptyline—ABCB1—testis—muscle cancer	0.000276	0.00219	CbGeAlD
Amitriptyline—Confusional state—Doxorubicin—muscle cancer	0.000275	0.00185	CcSEcCtD
Amitriptyline—Decreased appetite—Methotrexate—muscle cancer	0.000274	0.00185	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—muscle cancer	0.000272	0.00184	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—muscle cancer	0.000271	0.00183	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—muscle cancer	0.000268	0.00181	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—muscle cancer	0.000267	0.0018	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—muscle cancer	0.000266	0.0018	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—muscle cancer	0.000263	0.00178	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—muscle cancer	0.00026	0.00175	CcSEcCtD
Amitriptyline—Feeling abnormal—Methotrexate—muscle cancer	0.000259	0.00175	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—muscle cancer	0.000255	0.00172	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—muscle cancer	0.00025	0.00169	CcSEcCtD
Amitriptyline—Body temperature increased—Methotrexate—muscle cancer	0.000249	0.00168	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—muscle cancer	0.000246	0.00166	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—muscle cancer	0.000245	0.00165	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—muscle cancer	0.000242	0.00164	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—muscle cancer	0.00024	0.00162	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—muscle cancer	0.000237	0.0016	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—muscle cancer	0.000235	0.00159	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—muscle cancer	0.000233	0.00157	CcSEcCtD
Amitriptyline—Asthenia—Methotrexate—muscle cancer	0.000226	0.00152	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—muscle cancer	0.000225	0.00152	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—muscle cancer	0.000223	0.0015	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—muscle cancer	0.000216	0.00146	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—muscle cancer	0.000215	0.00145	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—muscle cancer	0.000215	0.00145	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—muscle cancer	0.000208	0.0014	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—muscle cancer	0.0002	0.00135	CcSEcCtD
Amitriptyline—Rash—Methotrexate—muscle cancer	0.000198	0.00134	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—muscle cancer	0.000198	0.00134	CcSEcCtD
Amitriptyline—Headache—Methotrexate—muscle cancer	0.000197	0.00133	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—muscle cancer	0.000195	0.00132	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—muscle cancer	0.000193	0.0013	CcSEcCtD
Amitriptyline—Nausea—Methotrexate—muscle cancer	0.000187	0.00126	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—muscle cancer	0.000186	0.00126	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—muscle cancer	0.00018	0.00122	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—muscle cancer	0.000173	0.00117	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—muscle cancer	0.000172	0.00116	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—muscle cancer	0.000172	0.00116	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—muscle cancer	0.000171	0.00115	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—muscle cancer	0.000162	0.00109	CcSEcCtD
Amitriptyline—OPRK1—Signaling Pathways—CNR1—muscle cancer	4.26e-05	0.00038	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—FOXO4—muscle cancer	4.25e-05	0.000379	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PTCH1—muscle cancer	4.23e-05	0.000377	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PTCH1—muscle cancer	4.23e-05	0.000377	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CNR1—muscle cancer	4.2e-05	0.000375	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CNR1—muscle cancer	4.2e-05	0.000375	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CNR1—muscle cancer	4.17e-05	0.000372	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—FOXO4—muscle cancer	4.16e-05	0.000371	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—CNR1—muscle cancer	4.14e-05	0.000369	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—FOXO1—muscle cancer	4.12e-05	0.000368	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CNR1—muscle cancer	4.08e-05	0.000364	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—KIT—muscle cancer	4.05e-05	0.000361	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—FOXO4—muscle cancer	4.04e-05	0.00036	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—MED12—muscle cancer	4.01e-05	0.000358	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—ENO2—muscle cancer	3.98e-05	0.000355	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IGF2—muscle cancer	3.98e-05	0.000355	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CNR1—muscle cancer	3.96e-05	0.000354	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—FH—muscle cancer	3.92e-05	0.000349	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—FOXO4—muscle cancer	3.87e-05	0.000345	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CNR1—muscle cancer	3.8e-05	0.000339	CbGpPWpGaD
Amitriptyline—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	3.79e-05	0.000338	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—MED12—muscle cancer	3.76e-05	0.000335	CbGpPWpGaD
Amitriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	3.73e-05	0.000333	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—KIT—muscle cancer	3.69e-05	0.000329	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PTCH1—muscle cancer	3.69e-05	0.000329	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—MED12—muscle cancer	3.68e-05	0.000328	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—MED12—muscle cancer	3.67e-05	0.000328	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—FOXO4—muscle cancer	3.67e-05	0.000328	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PTCH1—muscle cancer	3.67e-05	0.000327	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—FOXO1—muscle cancer	3.66e-05	0.000326	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—ENO2—muscle cancer	3.65e-05	0.000326	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—FOXO4—muscle cancer	3.64e-05	0.000324	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—FOXO4—muscle cancer	3.64e-05	0.000324	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CNR1—muscle cancer	3.6e-05	0.000322	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CNR1—muscle cancer	3.57e-05	0.000318	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CNR1—muscle cancer	3.57e-05	0.000318	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PTCH1—muscle cancer	3.51e-05	0.000313	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IGF2—muscle cancer	3.49e-05	0.000311	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IGF2—muscle cancer	3.44e-05	0.000307	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IGF2—muscle cancer	3.43e-05	0.000306	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—ENO2—muscle cancer	3.43e-05	0.000306	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IGF2—muscle cancer	3.41e-05	0.000304	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—ENO2—muscle cancer	3.36e-05	0.000299	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—ENO2—muscle cancer	3.35e-05	0.000299	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IGF2—muscle cancer	3.34e-05	0.000298	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IGF2—muscle cancer	3.24e-05	0.000289	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PTCH1—muscle cancer	3.24e-05	0.000289	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—FOXO1—muscle cancer	3.21e-05	0.000286	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—MDM2—muscle cancer	3.19e-05	0.000285	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PTCH1—muscle cancer	3.18e-05	0.000284	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—MED12—muscle cancer	3.18e-05	0.000284	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTCH1—muscle cancer	3.18e-05	0.000283	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—FOXO4—muscle cancer	3.17e-05	0.000283	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTCH1—muscle cancer	3.17e-05	0.000283	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—MED12—muscle cancer	3.16e-05	0.000282	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—FOXO1—muscle cancer	3.16e-05	0.000282	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—FOXO1—muscle cancer	3.16e-05	0.000282	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTCH1—muscle cancer	3.16e-05	0.000282	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—FOXO4—muscle cancer	3.15e-05	0.000281	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—KIT—muscle cancer	3.14e-05	0.00028	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—FOXO1—muscle cancer	3.14e-05	0.00028	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTCH1—muscle cancer	3.13e-05	0.000279	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	3.12e-05	0.000278	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CNR1—muscle cancer	3.11e-05	0.000278	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IGF2—muscle cancer	3.1e-05	0.000277	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CNR1—muscle cancer	3.09e-05	0.000276	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—FOXO1—muscle cancer	3.07e-05	0.000274	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—FH—muscle cancer	3.02e-05	0.00027	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—FOXO4—muscle cancer	3.02e-05	0.000269	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—FOXO1—muscle cancer	2.98e-05	0.000266	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CNR1—muscle cancer	2.96e-05	0.000264	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IGF2—muscle cancer	2.95e-05	0.000263	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IGF2—muscle cancer	2.92e-05	0.00026	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IGF2—muscle cancer	2.92e-05	0.00026	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—MDM2—muscle cancer	2.91e-05	0.000259	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ENO2—muscle cancer	2.9e-05	0.000259	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	2.9e-05	0.000258	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—ENO2—muscle cancer	2.88e-05	0.000257	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—FOXO1—muscle cancer	2.86e-05	0.000255	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—MED12—muscle cancer	2.84e-05	0.000253	CbGpPWpGaD
Amitriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.82e-05	0.000251	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—KIT—muscle cancer	2.79e-05	0.000249	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—FOXO4—muscle cancer	2.78e-05	0.000248	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—MED12—muscle cancer	2.77e-05	0.000247	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—FOXO4—muscle cancer	2.74e-05	0.000244	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—FOXO4—muscle cancer	2.73e-05	0.000244	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CNR1—muscle cancer	2.73e-05	0.000244	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—FOXO4—muscle cancer	2.72e-05	0.000243	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—FOXO4—muscle cancer	2.71e-05	0.000242	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—FOXO1—muscle cancer	2.71e-05	0.000242	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—FOXO4—muscle cancer	2.69e-05	0.00024	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CNR1—muscle cancer	2.69e-05	0.00024	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—FOXO1—muscle cancer	2.69e-05	0.00024	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—FOXO1—muscle cancer	2.69e-05	0.00024	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CNR1—muscle cancer	2.68e-05	0.000239	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	2.68e-05	0.000239	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CNR1—muscle cancer	2.67e-05	0.000239	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CNR1—muscle cancer	2.66e-05	0.000238	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CNR1—muscle cancer	2.64e-05	0.000235	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CNR1—muscle cancer	2.63e-05	0.000235	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—MED12—muscle cancer	2.61e-05	0.000233	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—MED12—muscle cancer	2.59e-05	0.000231	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ENO2—muscle cancer	2.59e-05	0.000231	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IGF2—muscle cancer	2.54e-05	0.000227	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IGF2—muscle cancer	2.53e-05	0.000226	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—ENO2—muscle cancer	2.53e-05	0.000225	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	2.49e-05	0.000222	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—MDM2—muscle cancer	2.47e-05	0.000221	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—VEGFA—muscle cancer	2.47e-05	0.000221	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CNR1—muscle cancer	2.44e-05	0.000218	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—KIT—muscle cancer	2.44e-05	0.000218	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—VEGFA—muscle cancer	2.42e-05	0.000216	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IGF2—muscle cancer	2.42e-05	0.000216	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—KIT—muscle cancer	2.41e-05	0.000215	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—KIT—muscle cancer	2.41e-05	0.000215	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—KIT—muscle cancer	2.39e-05	0.000213	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ENO2—muscle cancer	2.38e-05	0.000212	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ENO2—muscle cancer	2.36e-05	0.000211	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—KIT—muscle cancer	2.34e-05	0.000209	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—FOXO1—muscle cancer	2.34e-05	0.000209	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—FOXO1—muscle cancer	2.33e-05	0.000208	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—KIT—muscle cancer	2.27e-05	0.000203	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.27e-05	0.000202	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.26e-05	0.000201	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IGF2—muscle cancer	2.23e-05	0.000199	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—FOXO1—muscle cancer	2.23e-05	0.000199	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MED12—muscle cancer	2.21e-05	0.000197	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—VEGFA—muscle cancer	2.21e-05	0.000197	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IGF2—muscle cancer	2.2e-05	0.000196	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MDM2—muscle cancer	2.2e-05	0.000196	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IGF2—muscle cancer	2.19e-05	0.000196	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IGF2—muscle cancer	2.19e-05	0.000195	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IGF2—muscle cancer	2.18e-05	0.000194	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KIT—muscle cancer	2.18e-05	0.000194	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IGF2—muscle cancer	2.16e-05	0.000192	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IGF2—muscle cancer	2.15e-05	0.000192	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KIT—muscle cancer	2.07e-05	0.000184	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—FOXO1—muscle cancer	2.05e-05	0.000183	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KIT—muscle cancer	2.05e-05	0.000183	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KIT—muscle cancer	2.05e-05	0.000183	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.02e-05	0.000181	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—FOXO1—muscle cancer	2.02e-05	0.00018	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—FOXO1—muscle cancer	2.02e-05	0.00018	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ENO2—muscle cancer	2.02e-05	0.00018	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—FOXO1—muscle cancer	2.01e-05	0.000179	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—FOXO1—muscle cancer	2e-05	0.000179	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF2—muscle cancer	2e-05	0.000178	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—FOXO1—muscle cancer	1.99e-05	0.000177	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	1.98e-05	0.000177	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—VEGFA—muscle cancer	1.95e-05	0.000174	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MDM2—muscle cancer	1.93e-05	0.000172	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MDM2—muscle cancer	1.9e-05	0.000169	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MDM2—muscle cancer	1.9e-05	0.000169	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MDM2—muscle cancer	1.88e-05	0.000168	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—VEGFA—muscle cancer	1.88e-05	0.000168	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—TP53—muscle cancer	1.87e-05	0.000167	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.85e-05	0.000165	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MDM2—muscle cancer	1.84e-05	0.000165	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	1.84e-05	0.000164	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—TP53—muscle cancer	1.83e-05	0.000163	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MDM2—muscle cancer	1.79e-05	0.00016	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KIT—muscle cancer	1.78e-05	0.000159	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KIT—muscle cancer	1.77e-05	0.000158	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MDM2—muscle cancer	1.71e-05	0.000153	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MED12—muscle cancer	1.71e-05	0.000152	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KIT—muscle cancer	1.7e-05	0.000152	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—TP53—muscle cancer	1.67e-05	0.000149	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—VEGFA—muscle cancer	1.67e-05	0.000149	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MDM2—muscle cancer	1.63e-05	0.000145	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MDM2—muscle cancer	1.61e-05	0.000144	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MDM2—muscle cancer	1.61e-05	0.000144	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.58e-05	0.000141	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KIT—muscle cancer	1.57e-05	0.00014	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ENO2—muscle cancer	1.56e-05	0.000139	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KIT—muscle cancer	1.54e-05	0.000137	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KIT—muscle cancer	1.54e-05	0.000137	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KIT—muscle cancer	1.53e-05	0.000137	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KIT—muscle cancer	1.53e-05	0.000136	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KIT—muscle cancer	1.51e-05	0.000135	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KIT—muscle cancer	1.51e-05	0.000135	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TP53—muscle cancer	1.47e-05	0.000132	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—VEGFA—muscle cancer	1.46e-05	0.00013	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—VEGFA—muscle cancer	1.44e-05	0.000129	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—VEGFA—muscle cancer	1.44e-05	0.000128	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—VEGFA—muscle cancer	1.43e-05	0.000128	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TP53—muscle cancer	1.42e-05	0.000127	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MDM2—muscle cancer	1.4e-05	0.000125	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KIT—muscle cancer	1.4e-05	0.000125	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—VEGFA—muscle cancer	1.4e-05	0.000125	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MDM2—muscle cancer	1.4e-05	0.000125	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PTGS2—muscle cancer	1.39e-05	0.000124	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—VEGFA—muscle cancer	1.36e-05	0.000121	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MDM2—muscle cancer	1.34e-05	0.000119	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—VEGFA—muscle cancer	1.3e-05	0.000116	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTGS2—muscle cancer	1.27e-05	0.000114	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—muscle cancer	1.26e-05	0.000112	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—VEGFA—muscle cancer	1.24e-05	0.00011	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MDM2—muscle cancer	1.23e-05	0.00011	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—VEGFA—muscle cancer	1.22e-05	0.000109	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—VEGFA—muscle cancer	1.22e-05	0.000109	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MDM2—muscle cancer	1.21e-05	0.000108	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MDM2—muscle cancer	1.21e-05	0.000108	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MDM2—muscle cancer	1.21e-05	0.000108	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MDM2—muscle cancer	1.2e-05	0.000107	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—muscle cancer	1.19e-05	0.000106	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MDM2—muscle cancer	1.19e-05	0.000106	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MDM2—muscle cancer	1.19e-05	0.000106	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—muscle cancer	1.17e-05	0.000104	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—muscle cancer	1.17e-05	0.000104	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—muscle cancer	1.1e-05	9.86e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MDM2—muscle cancer	1.1e-05	9.85e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—muscle cancer	1.09e-05	9.71e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—muscle cancer	1.09e-05	9.7e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—muscle cancer	1.08e-05	9.64e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—VEGFA—muscle cancer	1.07e-05	9.52e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—VEGFA—muscle cancer	1.06e-05	9.47e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—muscle cancer	1.06e-05	9.44e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—muscle cancer	1.03e-05	9.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—VEGFA—muscle cancer	1.02e-05	9.06e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—muscle cancer	1.01e-05	9.01e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—muscle cancer	1e-05	8.96e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—muscle cancer	9.83e-06	8.78e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—muscle cancer	9.36e-06	8.36e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—muscle cancer	9.34e-06	8.33e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—muscle cancer	9.25e-06	8.25e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—muscle cancer	9.25e-06	8.25e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—muscle cancer	9.21e-06	8.22e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—muscle cancer	9.19e-06	8.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—muscle cancer	9.16e-06	8.18e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—muscle cancer	9.13e-06	8.15e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—muscle cancer	9.05e-06	8.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	9.02e-06	8.05e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—muscle cancer	9.02e-06	8.05e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—muscle cancer	8.8e-06	7.85e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	8.38e-06	7.48e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—muscle cancer	8.29e-06	7.4e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—muscle cancer	8.22e-06	7.34e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—muscle cancer	8.06e-06	7.19e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—muscle cancer	8.02e-06	7.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—muscle cancer	7.67e-06	6.85e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—muscle cancer	7.08e-06	6.31e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—muscle cancer	7.03e-06	6.27e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—muscle cancer	6.96e-06	6.21e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—muscle cancer	6.95e-06	6.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—muscle cancer	6.92e-06	6.18e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—muscle cancer	6.9e-06	6.16e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—muscle cancer	6.84e-06	6.1e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—muscle cancer	6.82e-06	6.08e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—muscle cancer	6.33e-06	5.65e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—muscle cancer	5.42e-06	4.84e-05	CbGpPWpGaD
